Based on these data, clinical trials to determine the efficacy of E-selectin blockade (GMI-1271/Uproleselan) in combination with chemotherapy to treat adult AML are now in progress (NCT03701308 and NCT03616470). Here, SELE is linked to acute myeloid leukemia.